CA Stock MarketDetailed Quotes
MBIO MindBio Therapeutics Corp
- 0.020
- -0.005-20.00%
15min DelayPost-Market Auction Session Dec 4 11:30 ET
2.70MMarket Cap-10000P/E (TTM)
0.020High0.020Low24.00KVolume0.020Open0.025Pre Close480.00Turnover0.08552wk High0.02%Turnover Ratio135.05MShares0.01552wk Low-0.002EPS TTM2.70MFloat Cap0.560Historical HighLossP/E (Static)135.05MShs Float0.015Historical Low-0.004EPS LYR0.00%Amplitude--Dividend TTM-0.51P/B1Lot Size--Div YieldTTM
MindBio Therapeutics Corp Key Stats
EPS
According to the latest financial report of MindBio Therapeutics Corp, the latest earnings per share (TTM) for the company is -0.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: AUD
Quarterly
Loading...
FCF
Interested in knowing about MindBio Therapeutics Corp's free cash flow? The latest report shows it as -80.37K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: AUD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of MindBio Therapeutics Corp shows that the company's current ratio is 0.02, indicating healthy liquidity.
Currency: AUD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of MindBio Therapeutics Corp, the quick ratio is 0.02, indicating that the company can meet its short-term debt obligations.
Currency: AUD
Quarterly
Loading...
ROE
Want to learn more about the financial health of MindBio Therapeutics Corp? The latest ROE figure is --, indicating that the company has stable profitability.
Currency: AUD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of MindBio Therapeutics Corp, the total asset return on investment (ROA) is -30.29%.
Currency: AUD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check MindBio Therapeutics Corp's latest financial report to see how their gross margin is doing - currently at --.
Currency: AUD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of MindBio Therapeutics Corp, the net profit margin is 41.95%, which is a good sign for its profitability.
Currency: AUD
Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data